\-\ Texto\\:\\ \ \(0\)\
\-\ see\\ above\ \(10\)\
\-\ chemotherapy\\ and\\ radiation\ \(25\)\
\-\ multiple\\ bilateral\\ lesions\\ which\\ are\\ high\\ signal\\ on\\ t2\\ sequences\\,\\ low\\ signal\\ on\\ t1\\ sequences\\ and\\ with\\ minimal\\ mass\\ effect\\.\\ \\ some\\ of\\ the\\ lesions\\ reveal\\ restricted\\ diffusion\\ on\\ dwi\\ images\\.\\ \\ the\\ lesions\\ enhance\\ irregularly\\.\ \(0\)\
\-\ intravascular\\ lymphoma\\ \\(large\\ cell\\)\\ lymphoma\\,\\ of\\ the\\ b\\-cell\\ phenotype\\ \\(cd20\\ positive\\)\\.\ \(0\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ \\â\\€\\¢\\ septic\\ emboli\ \(0\)\
\-\ \\â\\€\\¢\\ sarcoidosis\ \(1\)\
\-\ \\â\\€\\¢\\ adem\ \(0\)\
\-\ \\â\\€\\¢\\ aggressive\\ ms\ \(0\)\
\-\ \\â\\€\\¢\\ multifocal\\ glioma\ \(0\)\
\-\ 38\\ year\\ old\\ man\\ with\\ a\\ clinical\\ diagnosis\\ of\\ ms\\.\\ \\ treated\\ with\\ high\\ dose\\ steroids\\ for\\ two\\ months\\.\\ \\ now\\ presents\\ with\\ obtundation\\,\\ visual\\ loss\\,\\ and\\ bilateral\\ extremity\\ weakness\\.\ \(0\)\
\-\ intravascular\\ lymphoma\\ is\\ also\\ called\\ angiocentric\\ lymphoma\\.\\ \\ restricted\\ diffusion\\ \\-\\ as\\ is\\ seen\\ here\\ \\-\\ is\\ typical\\ in\\ highly\\ cellular\\ lesions\\ such\\ as\\ lymphoma\\;\\ and\\,\\ this\\ finding\\ is\\ uncommon\\ in\\ multiple\\ sclerosis\\.\ \(0\)\
\-\ it\\ is\\ possible\\ that\\ the\\ clinical\\ diagnosis\\ of\\ ms\\ was\\ incorrect\\ and\\ the\\ confusing\\ mixture\\ of\\ neurologic\\ problems\\ were\\ related\\ to\\ the\\ intravascular\\ lymphoma\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ intravascular\\:\\ 0\\.10184110563958368\ \(0\)\
\-\ lymphoma\\:\\ 0\\.0861952459196289\ \(0\)\
\-\ ms\\:\\ 0\\.08059452673971422\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.05530638887985487\ \(0\)\
\-\ lesions\\:\\ 0\\.053824953090445826\ \(0\)\
\-\ angiocentric\\:\\ 0\\.05185599072921469\ \(0\)\
\-\ incorrect\\:\\ 0\\.04777865437297972\ \(0\)\
\-\ restricted\\:\\ 0\\.04626725295741326\ \(0\)\
\-\ diffusion\\:\\ 0\\.04500100984926778\ \(0\)\
\-\ phenotype\\:\\ 0\\.04238870889136705\ \(0\)\
\-\ sequences\\:\\ 0\\.041982286491835434\ \(0\)\
\-\ cd20\\:\\ 0\\.04040946044065403\ \(0\)\
\-\ obtundation\\:\\ 0\\.039623981660509774\ \(0\)\
\-\ confusing\\:\\ 0\\.039623981660509774\ \(0\)\
\-\ mixture\\:\\ 0\\.0342340361788971\ \(0\)\
\-\ cellular\\:\\ 0\\.03367338806240107\ \(0\)\
\-\ irregularly\\:\\ 0\\.03269071697614715\ \(0\)\
\-\ b\\-cell\\:\\ 0\\.03128829919117657\ \(0\)\
\-\ clinical\\:\\ 0\\.030933056471364757\ \(0\)\
\-\ adem\\:\\ 0\\.03030562810492266\ \(0\)\
\-\ high\\:\\ 0\\.027512306600903712\ \(0\)\
\-\ emboli\\:\\ 0\\.0272109628349416\ \(0\)\
\-\ multifocal\\:\\ 0\\.027035357169355245\ \(0\)\
\-\ 38\\:\\ 0\\.026781403217206956\ \(0\)\
\-\ dwi\\:\\ 0\\.02669913120559084\ \(0\)\
\-\ signal\\:\\ 0\\.026506756826738573\ \(0\)\
\-\ septic\\:\\ 0\\.026381088727530394\ \(0\)\
\-\ called\\:\\ 0\\.026381088727530394\ \(0\)\
\-\ dose\\:\\ 0\\.026304194130075377\ \(0\)\
\-\ here\\:\\ 0\\.026228291748687686\ \(0\)\
\-\ aggressive\\:\\ 0\\.02459287903374625\ \(0\)\
\-\ uncommon\\:\\ 0\\.02459287903374625\ \(0\)\
\-\ bilateral\\:\\ 0\\.02439785563899346\ \(0\)\
\-\ enhance\\:\\ 0\\.024314042334366345\ \(0\)\
\-\ highly\\:\\ 0\\.024206106224553423\ \(0\)\
\-\ steroids\\:\\ 0\\.023645458108057394\ \(0\)\
\-\ problems\\:\\ 0\\.023268858938851916\ \(0\)\
\-\ diagnosis\\:\\ 0\\.023084933303299058\ \(0\)\
\-\ visual\\:\\ 0\\.022787505890336436\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.022704066860971983\ \(0\)\
\-\ glioma\\:\\ 0\\.022662787021803476\ \(0\)\
\-\ reveal\\:\\ 0\\.022381665469824955\ \(0\)\
\-\ \\-\\:\\ 0\\.021549746573039572\ \(0\)\
\-\ multiple\\:\\ 0\\.02117418827622669\ \(0\)\
\-\ neurologic\\:\\ 0\\.020991143245917717\ \(0\)\
\-\ related\\:\\ 0\\.020748537607482135\ \(0\)\
\-\ typical\\:\\ 0\\.02015556878911763\ \(0\)\
\-\ minimal\\:\\ 0\\.01979105864941646\ \(0\)\
\-\ weakness\\:\\ 0\\.018668302076637555\ \(0\)\
\-\ above\\:\\ 0\\.01842316856839892\ \(0\)\
\-\ extremity\\:\\ 0\\.018383288056720223\ \(0\)\
\-\ sclerosis\\:\\ 0\\.018054795490743205\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.01801732814788744\ \(0\)\
\-\ effect\\:\\ 0\\.017797401488642617\ \(0\)\
\-\ now\\:\\ 0\\.017183032880597925\ \(0\)\
\-\ possible\\:\\ 0\\.016929307169906305\ \(0\)\
\-\ is\\:\\ 0\\.01653796407013899\ \(0\)\
\-\ radiation\\:\\ 0\\.016495595585660803\ \(0\)\
\-\ positive\\:\\ 0\\.016311091707553627\ \(0\)\
\-\ finding\\:\\ 0\\.016200361794344007\ \(0\)\
\-\ t1\\:\\ 0\\.015932326683672022\ \(0\)\
\-\ such\\:\\ 0\\.015713722293181485\ \(0\)\
\-\ some\\:\\ 0\\.015264283846275054\ \(0\)\
\-\ as\\:\\ 0\\.015206794186989739\ \(0\)\
\-\ treated\\:\\ 0\\.015046181388728583\ \(0\)\
\-\ see\\:\\ 0\\.015001277713110519\ \(0\)\
\-\ loss\\:\\ 0\\.014590965720402586\ \(0\)\
\-\ two\\:\\ 0\\.014396066103623562\ \(0\)\
\-\ t2\\:\\ 0\\.014226992757355011\ \(0\)\
\-\ low\\:\\ 0\\.013977459134508232\ \(0\)\
\-\ months\\:\\ 0\\.013729066439353337\ \(0\)\
\-\ cell\\:\\ 0\\.013577886538714624\ \(0\)\
\-\ on\\:\\ 0\\.012774547277036965\ \(0\)\
\-\ metastatic\\:\\ 0\\.012653584727153472\ \(0\)\
\-\ \\;\\:\\ 0\\.011914242285015256\ \(0\)\
\-\ man\\:\\ 0\\.011887834371117642\ \(0\)\
\-\ were\\:\\ 0\\.011413449039352477\ \(0\)\
\-\ it\\:\\ 0\\.011299108144311863\ \(0\)\
\-\ large\\:\\ 0\\.010991426069594586\ \(0\)\
\-\ presents\\:\\ 0\\.010268495855928976\ \(0\)\
\-\ seen\\:\\ 0\\.009933103618045237\ \(0\)\
\-\ also\\:\\ 0\\.009909527021589126\ \(0\)\
\-\ images\\:\\ 0\\.009642728776172671\ \(0\)\
\-\ which\\:\\ 0\\.009383203454367934\ \(0\)\
\-\ that\\:\\ 0\\.008682239579757785\ \(0\)\
\-\ \\(\\:\\ 0\\.008498373249927771\ \(0\)\
\-\ \\)\\:\\ 0\\.008394561083685942\ \(0\)\
\-\ disease\\:\\ 0\\.008216103183621789\ \(0\)\
\-\ \\,\\:\\ 0\\.007962060750508452\ \(0\)\
\-\ mass\\:\\ 0\\.006990947099691556\ \(0\)\
\-\ are\\:\\ 0\\.006852199250174128\ \(0\)\
\-\ was\\:\\ 0\\.005813397189492276\ \(0\)\
\-\ this\\:\\ 0\\.0056537483136125475\ \(0\)\
\-\ year\\:\\ 0\\.005624148642781851\ \(0\)\
\-\ and\\:\\ 0\\.0052943825215358365\ \(0\)\
\-\ old\\:\\ 0\\.005146674099189733\ \(0\)\
\-\ in\\:\\ 0\\.0049576144722382936\ \(0\)\
\-\ the\\:\\ 0\\.004879386518951498\ \(0\)\
\-\ for\\:\\ 0\\.004288871462604206\ \(0\)\
\-\ of\\:\\ 0\\.0034265823764114242\ \(0\)\
\-\ with\\:\\ 0\\.00275303943740917\ \(0\)\
\-\ to\\:\\ 0\\.002512165343782272\ \(0\)\
\-\ a\\:\\ 0\\.0023329400106976545\ \(0\)\
\-\ \\.\\:\\ 0\\.0020882080057262513\ \(0\)\
